Literature DB >> 18806093

Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity.

Gregory G Martin1, Barbara P Atshaves, Avery L McIntosh, John T Mackie, Ann B Kier, Friedhelm Schroeder.   

Abstract

Previous work conducted in our laboratory suggested a role for liver fatty acid-binding protein (L-FABP) in obesity that develops in aging female L-FABP gene-ablated (-/-) mice. To examine this possibility in more detail, cohorts of wild-type (+/+) and L-FABP (-/-) female mice were fed a standard, low-fat, nonpurified rodent diet for up to 18 mo. Various obesity-related parameters were examined, including body weight and fat and lean tissue mass. Obesity in (-/-) mice was associated with increased expression of nuclear receptors that induce PPARalpha (e.g. hepatocyte nuclear factor 1alpha, genotype effect) and of PPARalpha-regulated proteins involved in uptake of free (lipoprotein lipase and fatty acid transport protein, genotype, and/or age effect) and esterified (scavenger receptor class B type 1, genotype effect) long-chain fatty acids (LCFA). Hepatic total lipid and neutral lipid levels were not affected by age or genotype, consistent with absence of gross and histologic steatosis. There was increased mRNA expression of liver proteins involved in LCFA oxidation [mitochondrial 3-oxoacyl-CoA thiolase (genotype effect) and butyryl-CoA dehydrogenase (genotype and/or age effect)], increased expression of LCFA esterification enzymes [glycerol-3-phosphate acyltransferase (age x genotype effect) and acyl-CoA:cholesterol acyltransferase-2 (genotype and/or age effect)], and increased expression of proteins involved in intracellular transfer and secretion of esterified LCFA [liver microsomal triacylglycerol transfer protein (genotype effect), serum apolipoprotein (apo) B (genotype or age effect), and liver apoB (age and age x genotype effect)]. The data support a working model in which obesity development in these mice results from shifts toward reduced energy expenditure and/or more efficient energy uptake in the gut.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806093      PMCID: PMC2835297          DOI: 10.1093/jn/138.10.1859

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  41 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice.

Authors:  G Vassileva; L Huwyler; K Poirier; L B Agellon; M J Toth
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

3.  Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice.

Authors:  W A Banks; C M Clever; C L Farrell
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-06       Impact factor: 4.310

4.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.

Authors:  Barbara P Atshaves; Avery L McIntosh; Danilo Landrock; H Ross Payne; John T Mackie; Nobuyo Maeda; Judith Ball; Friedhelm Schroeder; Ann B Kier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-26       Impact factor: 4.052

6.  Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.

Authors:  C Wolfrum; C M Borrmann; T Borchers; F Spener
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus.

Authors:  J W Lawrence; D J Kroll; P I Eacho
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

8.  Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  Heather A Hostetler; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

Review 9.  Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

Authors:  P Escher; W Wahli
Journal:  Mutat Res       Date:  2000-03-17       Impact factor: 2.433

10.  Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice.

Authors:  Gregory G Martin; Barbara P Atshaves; Avery L McIntosh; John T Mackie; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-08-25       Impact factor: 4.052

View more
  24 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.

Authors:  Angela M Gajda; Yin Xiu Zhou; Luis B Agellon; Susan K Fried; Sarala Kodukula; Walter Fortson; Khamoshi Patel; Judith Storch
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

3.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

4.  Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes.

Authors:  Anca D Petrescu; Huan Huang; Gregory G Martin; Avery L McIntosh; Stephen M Storey; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-13       Impact factor: 4.052

Review 5.  Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.

Authors:  Angela M Gajda; Judith Storch
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-14       Impact factor: 4.006

6.  Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor, REDD1.

Authors:  Nora K McGhee; Leonard S Jefferson; Scot R Kimball
Journal:  J Nutr       Date:  2009-03-18       Impact factor: 4.798

7.  Phenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers.

Authors:  Elizabeth P Newberry; Susan Kennedy; Yan Xie; Jianyang Luo; Hui Jiang; Daniel S Ory; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

8.  Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2016-07-23       Impact factor: 1.880

Review 9.  Fluorescence techniques using dehydroergosterol to study cholesterol trafficking.

Authors:  Avery L McIntosh; Barbara P Atshaves; Huan Huang; Adalberto M Gallegos; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2008-06-07       Impact factor: 1.880

10.  Hepatic phenotype of liver fatty acid binding protein gene-ablated mice.

Authors:  Gregory G Martin; Barbara P Atshaves; Huan Huang; Avery L McIntosh; Brad J Williams; Pei-Jing Pai; David H Russell; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.